These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 488668)
1. The action of neurotensin on neurones in the nucleus accumbens and cerebellum of the rat. McCarthy PS; Walker RJ; Yajima H; Kitagawa K; Woodruff GN Gen Pharmacol; 1979; 10(4):331-3. PubMed ID: 488668 [No Abstract] [Full Text] [Related]
2. Neurotensin microinjection into the nucleus accumbens antagonizes dopamine-induced increase in locomotion and rearing. Kalivas PW; Nemeroff CB; Prange AJ Neuroscience; 1984 Apr; 11(4):919-30. PubMed ID: 6738859 [TBL] [Abstract][Full Text] [Related]
3. Differential effects of neurotensin on dopamine release in the caudal and rostral nucleus accumbens: a combined in vivo electrochemical and electrophysiological study. Sotty F; Soulière F; Brun P; Chouvet G; Steinberg R; Soubrié P; Renaud B; Suaud-Chagny MF Neuroscience; 1998 Aug; 85(4):1173-82. PubMed ID: 9681955 [TBL] [Abstract][Full Text] [Related]
4. Actions of cocaine on rat nucleus accumbens neurones in vitro. Uchimura N; North RA Br J Pharmacol; 1990 Apr; 99(4):736-40. PubMed ID: 2193689 [TBL] [Abstract][Full Text] [Related]
5. Effects of neurotensin on dopamine release and metabolism in the rat striatum and nucleus accumbens: cross-validation using in vivo voltammetry and microdialysis. Blaha CD; Coury A; Fibiger HC; Phillips AG Neuroscience; 1990; 34(3):699-705. PubMed ID: 2352647 [TBL] [Abstract][Full Text] [Related]
6. Inhibitory effects of thyrotropin-releasing hormone on neuronal activity in the nucleus accumbens. Takatani T; Sasa M; Akaike A; Takaori S Neuropharmacology; 1987 Sep; 26(9):1389-94. PubMed ID: 3118234 [TBL] [Abstract][Full Text] [Related]
7. Neuromedin N mimics the actions of neurotensin in the ventral tegmental area but not in the nucleus accumbens. Kalivas PW; Richardson-Carlson R; Duffy P J Pharmacol Exp Ther; 1986 Sep; 238(3):1126-31. PubMed ID: 3755755 [TBL] [Abstract][Full Text] [Related]
8. The effects of neurotensin and [D-Tyr11]-NT on the hyperactivity induced by intra-accumbens administration of a potent dopamine receptor agonist. Jolicoeur FB; Rivest R; St-Pierre S; Gagné MA; Dumais M Neuropeptides; 1985 Apr; 6(2):143-56. PubMed ID: 2987745 [TBL] [Abstract][Full Text] [Related]
9. Neurotensin and cholecystokinin microinjected into the ventral tegmental area modulate microdialysate concentrations of dopamine and metabolites in the posterior nucleus accumbens. Laitinen K; Crawley JN; Mefford IN; De Witte P Brain Res; 1990 Jul; 523(2):342-6. PubMed ID: 1698106 [TBL] [Abstract][Full Text] [Related]
10. Effects of peptides on neurones in the substantia nigra and nucleus accumbens [proceedings]. Pinnock RD; Turnbull MJ; Woodruff GN Br J Pharmacol; 1979 Nov; 67(3):429P-430P. PubMed ID: 497554 [No Abstract] [Full Text] [Related]
11. Effects of haloperidol and sulpiride on dopamine-induced inhibition of nucleus accumbens neurons. Akaike A; Sasa M; Takaori S Life Sci; 1983 Jun; 32(23):2649-53. PubMed ID: 6855460 [TBL] [Abstract][Full Text] [Related]
13. Facilitation of GABA release by neurotensin is associated with a reduction of dopamine release in rat nucleus accumbens. Tanganelli S; O'Connor WT; Ferraro L; Bianchi C; Beani L; Ungerstedt U; Fuxe K Neuroscience; 1994 Jun; 60(3):649-57. PubMed ID: 7936192 [TBL] [Abstract][Full Text] [Related]
14. Central integration of cardiovascular and drinking responses elicited by central administration of angiotensin II: divergence of regulation by the ventral tegmental area and nucleus accumbens. Jones DL Can J Physiol Pharmacol; 1986 Jul; 64(7):1011-6. PubMed ID: 3768792 [TBL] [Abstract][Full Text] [Related]
15. [Influence of monoamines on the dl-tetrahydropalmatine-induced inhibition of single-unit activity in the nucleus accumbens]. Liu GQ; Wu HQ; Xie L; Mei XY Yao Xue Xue Bao; 1985 Jul; 20(7):500-4. PubMed ID: 2869636 [No Abstract] [Full Text] [Related]
16. Enhancement of dopamine actions on rat nucleus accumbens neurones in vitro after methamphetamine pre-treatment. Higashi H; Inanaga K; Nishi S; Uchimura N J Physiol; 1989 Jan; 408():587-603. PubMed ID: 2550628 [TBL] [Abstract][Full Text] [Related]
17. Presynaptic modulation of dopamine-induced locomotor activity of oxotremorine in nucleus accumbens of the rat. de Belleroche JS; Winn P; Murzi E; Williams SF; Herberg LJ J Neural Transm; 1982; 54(3-4):134-43. PubMed ID: 6813423 [No Abstract] [Full Text] [Related]
18. Pharmacological evidence for common mechanisms underlying the effects of neurotensin and neuroleptics on in vivo dopamine efflux in the rat nucleus accumbens. Blaha CD; Phillips AG Neuroscience; 1992 Aug; 49(4):867-77. PubMed ID: 1436486 [TBL] [Abstract][Full Text] [Related]
19. Effects of CCK-8 in the nucleus accumbens. DeFrance JF; Sikes RW; Chronister RB Peptides; 1984; 5(1):1-6. PubMed ID: 6324144 [TBL] [Abstract][Full Text] [Related]
20. Topographical analysis of nucleus accumbens sites at which cholecystokinin potentiates dopamine-induced hyperlocomotion in the rat. Crawley JN; Hommer DW; Skirboll LR Brain Res; 1985 Jun; 335(2):337-41. PubMed ID: 4005562 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]